Clinical trial
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
NCT00004682 is registered in ClinicalTrials.gov with University of Texas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
- Lead sponsor
- University of Texas
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 31, 1995
- Completion date
- March 31, 1999
- Enrollment
- 100
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.